Resources
Browse materials to learn more about ORGOVYX® (relugolix).
Cardiovascular Burden in Prostate Cancer and Implications of ADT
View PDF: Cardiovascular Burden in Prostate Cancer and Implications of ADT (opens in a new tab)HERO Testosterone Recovery Overview (Tutrone R et al Eur Urol Oncol 2024)
View PDF: HERO Testosterone Recovery Overview (Tutrone R et al Eur Urol Oncol 2024) (opens in a new tab)ORGOVYX (relugolix) US Prescribing Information
View PDF: ORGOVYX (relugolix) US Prescribing Information (opens in a new tab)Overview of Relugolix in Advanced Prostate Cancer Infographic
View PDF: Overview of Relugolix in Advanced Prostate Cancer Infographic (opens in a new tab)Overview of Relugolix in Advanced Prostate Cancer Slide Deck
View PDF: Overview of Relugolix in Advanced Prostate Cancer Slide Deck (opens in a new tab)Contact Us
Connect with an MSL
Find a Medical Science Liaison (MSL) in your region and specialty.
Stay up to date
Sign up to receive the latest clinical data, scientific resources and news from Sumitomo Pharma America Medical Affairs.
Have a medical question?
Our Medical Information team can help you find the information you need.
+1 (800) 739-0565Monday–Friday, 8 AM–8 PM ET
Report an Adverse Event or Product Complaint
1 (877) 737-7226
Email Drug Safety24 hours, 7 days a week
Please report any side effects related to any Sumitomo Pharma America, Inc. medication by contacting us. You may also contact the US Food and Drug Administration (FDA) directly by visiting www.fda.gov/Safety/MedWatch or calling 1-800-FDA-1088.